As BCMA has a functional role in MM, such BCMA-independent growth on one hand may indicate a more aggressive phenotype, but it may also suggest a new vulnerability that can be targeted by alternative therapies. This evidence concerns the gene TNFRSF17 and Miyoshi myopathy.